/
ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy

ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy - PowerPoint Presentation

BadassBabe
BadassBabe . @BadassBabe
Follow
342 views
Uploaded On 2022-08-01

ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy - PPT Presentation

From ESH 2016 LB 1 JeanPierre Fauvel MD CHU Lyon Hôpital E Herriot Lyon France Overview Online risk prediction tool created to aid optimizing treatment of diabetic nephropathy ID: 931824

bayesian patients protect alice patients bayesian alice protect study online variables data event diabetic nephropathy tool risk lyon model

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "ALICE-PROTECT Study Yields Online Risk P..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy

From ESH 2016 | LB 1:

Jean-Pierre

Fauvel

, MD

CHU Lyon,

Hôpital

E Herriot, Lyon,

France

Slide2

Overview

Online risk prediction tool created to aid optimizing treatment of diabetic nephropathy

ALICE-PROTECT study data of patients with type 2 diabetes (T2D) and diabetic nephropathy used for Bayesian modeling

Online tool predicts 2-year risk of cardiovascular (CV) event

Access for online calculator:

https://www.hed.cc/?s=cvevent&t=CV%20Event

Slide3

ALICE-PROTECT Study

Prospective, observational study

Primary outcome: number of patients at 2 years with blood pressure <130/80

mmHg

and proteinuria <0.5 g daily

986 patients, mean age 70 years, mean

eGFR

42 ml/min/1.73 m

2

, 66% patients had proteinuria >1 g daily

630 patients alive at 2 years; 39 patients had CV event during Year 1; 26 patients died from CV

cause

Reference

: Joly D et al.

Diabetes Res

Clin

Pract

2015

Slide4

Proportion of Patients with a Cardiovascular Event in ALICE-PROTECT

% of the population

Slide5

Variables in Bayesian Model

Patient Characteristics

Age, sex, body mass index, blood pressure, ethnicity, smoking habits

Medical History

Stroke, sleep apnea, peripheral arterial disease, ischemic heart disease, heart failure, diabetes duration, hypertension duration, retinopathy

Slide6

Variables in Bayesian Model

Biology

eGFR, potassium, low-density lipoprotein

cholesterol,

HbA

1c

, proteinuria, hemoglobin

Treatment

Renin angiotensin system blockers, ASE, insulin, statin, diuretics, antithrombotic agent

Slide7

Variables in Bayesian Model

Created Bayesian network to simulate data, using original data from ALICE-PROTECT study

Simulation calibrated with 2000 simulated individual data, 1000 with and 1000 without a CV event; multiple links found between variables

Bayesian network mimics usual medical thinking by physicians, analyzes large number of

variables

Used increasingly as diagnostic tools for medical decision

making

Slide8

ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy

From ESH 2016 | LB 1:

Jean-Pierre

Fauvel

, MD

CHU Lyon,

Hôpital

E Herriot, Lyon,

France